Jiuzhitang Co., Ltd. (SHE:000989)
8.81
+0.07 (0.80%)
Jun 20, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Pharmaceutical Industry | 3.49B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Industry Growth | 5.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical | 82.32M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Growth | -82.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business | 23.86M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business Growth | 38.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Inter-segment Elimination | -636.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Inter-segment Elimination Growth | -17.83% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Chinese Patent Medicine | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Chinese Patent Medicine Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Medicine | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Medicine Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biopharmaceuticals | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biopharmaceuticals Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
China | 2.96B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | -2.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|